OVIT (OVIT) Stock Price & Analysis
OVIT (OVIT) rose 0.00% to USD 0 as of June 10, 2026 at 09:40 UTC, according to Nexqual real-time market data.
OVIT last closed at USD 0; the session ranged USD 0–0 on volume of 5,650 shares. Market capitalization is $2,355, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 09:40 UTC.
Key Statistics (as of June 10, 2026 at 09:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 5,650 shares |
| Market Cap | $2,355 |
| Exchange | PNK |
Technical Analysis (OVIT)
Nexqual's technical model rates OVIT "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 09:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (OVIT)
Wall Street analysts rate OVIT "None", per Nexqual as of June 10, 2026 at 09:40 UTC.
| Consensus Rating | None |
|---|
Earnings (OVIT)
Source: Nexqual, June 10, 2026 at 09:40 UTC.
Financials & Fundamentals (OVIT)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.01 |
| Total Cash | $61,270 |
| Total Debt | $479,298 |
| Free Cash Flow | $-635,235 |
Source: Nexqual, June 10, 2026 at 09:40 UTC.
Financial Health Score (OVIT)
Nexqual rates OVIT's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $61K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$264K |
| Efficiency | Mixed — No data |
Ownership (OVIT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 23.56M |
Source: Nexqual, June 10, 2026 at 09:40 UTC.
Leadership (OVIT)
OVIT is led by Alexander L. Weis (age 75), Chairman, CEO, President, CFO, Principal Accounting Officer and Secretary, per Nexqual as of June 10, 2026 at 09:40 UTC.
| Chairman, CEO, President, CFO, Principal Accounting Officer and Secretary | Alexander L. Weis (age 75) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARNI | ARNO THERAPEUTICS INC | USD 0 | ▲ 0% |
| FPMI | FLUOROPHARMA MEDICAL INC | USD 0 | ▲ 0% |
| BZYR | Burzynski Research Institute, I | USD 0.01 | ▲ 0% |
| HSTC | HST Global, Inc. | USD 0.7 | ▲ 0% |
| PFND | PATHFINDER CELL THERAPY INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:40 UTC. This page is informational and not investment advice.